Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2

Journal of Cell Biology

Volumn 169, Issue 2, 2005, Pages 239-243

  Saharinen, Pipsa ^a   Kerkelä, Katja ^a   Ekman, Niklas ^a   Marron, Marie ^b,e   Brindle, Nicholas ^b   Lee, Gyun Min ^c   Augustin, Hellmut ^d   Koh, Gou Young ^c   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d TUMOR BIOLOGY CENTER   (Germany)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 4; CHIMERIC PROTEIN; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; TIE 1 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CHIMERA; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANGIOPOIETINS; CELL LINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; PHOSPHORYLATION; RECEPTOR, TIE-1; RECEPTOR, TIE-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 18544365981     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200411105     Document Type: Article

References (36)

1. Ades, E.W., F.J. Candal, R.A. Swerlick, V.G. George, S. Summers, D.C. Bosse, and T.J. Lawley. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99:683-690.
2. Carlson, T.R., Y. Feng, P.C. Maisonpierre, M. Mrksich, and A.O. Morla. 2001. Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276:26516-26525.
3. Cho, C.H., R.A. Kammerer, H.J. Lee, M.O. Steinmetz, Y.S. Ryu, S.H. Lee, K. Yasunaga, K.T. Kim, I. Kim, H.H. Choi, et al. 2004a. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. USA. 101:5547-5552.
4. Cho, C.H., R.A. Kammerer, H.J. Lee, K. Yasunaga, K.T. Kim, H.H. Choi, W. Kim, S.H. Kim, S.K. Park, G.M. Lee, and G.Y. Koh. 2004b. Designed angiopoietin-1 variant. COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA. 101:5553-5558.
5. Davis, S., T.H. Aldrich, P.P. Jones, A. Acheson, D.L. Compton, V. Jain, T.E. Ryan, J. Bruno, C. Radziejewski, P.C. Maisonpierre, and G.D. Yancopoulos. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1161-1169.
6. Dumont, D.J., G. Gradwohl, G.H. Fong, M.C. Puri, M. Gertsenstein, A. Auerbach, and M.L. Breitman. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1897-1909.
7. Dumont, D.J., G.H. Fong, M.C. Puri, G. Gradwohl, K. Alitalo, and M.L. Breitman. 1995. Vascularization of the mouse embryo: a study of flk-1. tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203:80-92.
8. Edgell, C.J., C.C. McDonald, and J.B. Graham. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA. 80:3734-3737.
9. Harris, A.L., P. Reusch, B. Barleon, C. Hang, N. Dobbs, and D. Marme. 2001. Soluble Tie2 and Fit1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Clin. Cancer Res. 7:1992-1997.
10. Hashiyama, M., A. Iwama, K. Ohshiro, K. Kurozumi, K. Yasunaga, Y. Shimizu, Y. Masuho, I. Matsuda, N. Yamaguchi, and T. Suda. 1996. Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells. Blood. 87:93-101.
11. Jones, N., K. Iljin, D.J. Dumont, and K. Alitalo. 2001. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2:257-267.
12. Kaipainen, A., T. Vlaykova, E. Hatva, T. Bohling, A. Jekunen, S. Pyrhonen, and K. Alitalo. 1994. Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res. 54:6571-6577.
13. Kim, I., H.G. Kim, H. Kim, H.H. Kim, S.K. Park, C.S. Uhm, Z.H. Lee, and G.Y. Koh. 2000. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 346:603-610.
14. Koblizek, T.I., C. Weiss, G.D. Yancopoulos, U. Deutsch, and W. Risau. 1998. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8:529-532.
15. Kontos, C.D., T.P. Stauffer, W.P. Yang, J.D. York, L. Huang, M.A. Blanar, T. Meyer, and K.G. Peters. 1998. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 18:4131-4140.
16. Kontos, C.D., E.H. Cha, J.D. York, and K.G. Peters. 2002. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol. Cell. Biol. 22:1704-1713.
17. Korhonen, J., J. Partanen, E. Armstrong, A. Vaahtokari, K. Elenius, M. Jalkanen, and K. Alitalo. 1992. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood. 80:2548-2555.
18. Korhonen, J., A. Polvi, J. Partanen, and K. Alitalo. 1994. The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene. 9:395-403.
19. Lee, H.J., C.H. Cho, S.J. Hwang, H.H. Choi, K.T. Kim, S.Y. Ahn, J.H. Kim, J.L. Oh, G.M. Lee, and G.Y. Koh. 2004. Biological characterization of angiopoietin-3 and angiopoietin-4. FASEB J. 18:1200-1208.
20. Maisonpierre, P.C., C. Suri, P.F. Jones, S. Bartunkova, S.J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T.H. Aldrich, N. Papadopoulos, et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 277:55-60.
21. Makinen, T., T. Veikkola, S. Mustjoki, T. Karpanen, B. Catimel, E.C. Nice, L. Wise, A. Mercer, H. Kowalski, D. Kerjaschki, et al. 2001. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20:4762-4773.
22. Marron, M.B., D.P. Hughes, M.D. Edge, C.L. Forder, and N.P. Brindle. 2000. Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J. Biol. Chem. 275:39741-39746.
23. Partanen, J., and D.J. Dumont. 1999. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. Curr. Top. Microbiol. Immunol. 237:159-172.
24. Partanen, J., E. Armstrong, T.P. Makela, J. Korhonen, M. Sandberg, R. Renkonen, S. Knuutila, K. Huebner, and K. Alitalo. 1992. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell. Biol. 12:1698-1707.
25. Peters, K.G., C.D. Kontos, P.C. Lin, A.L. Wong, P. Rao, L. Huang, M.W. Dewhirst, and S. Sankar. 2004. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog. Horm. Res. 59:51-71.
26. Puri, M.C., and A. Bernstein. 2003. Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc. Natl. Acad. Sci. USA. 100:12753-12758.
27. Puri, M.C., J. Rossant, K. Alitalo, A. Bernstein, and J. Partanen. 1995. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14:5884-5891.
28. Puri, M.C., J. Partanen, J. Rossant, and A. Bernstein. 1999. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development. 126:4569-4580.
29. Saharinen, P., N. Ekman, K. Sarvas, P. Parker, K. Alitalo, and O. Silvennoinen. 1997. The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. Blood. 90:4341-4353.
30. Sato, T.N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:70-74.
31. Scharpfenecker, M., U. Fiedler, Y. Reiss, and H.G. Augustin. 2005. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci. 188:771-780.
32. Suri, C., P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, S. Davis, T.N. Sato, and G.D. Yancopoulos. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180.
33. Teichert-Kuliszewska, K., P.C. Maisonpierre, N. Jones, A.I. Campbell, Z. Master, M.P. Bendeck, K. Alitalo, D.J. Dumont, G.D. Yancopoulos, and D.J. Stewart. 2001. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 49:659-670.
34. Tzahar, E., R. Pinkas-Kramarski, J.D. Moyer, L.N. Klapper, I. Alroy, G. Levkowitz, M. Shelly, S. Henis, M. Eisenstein, B.J. Ratzkin, et al. 1997. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 16:4938-4950.
35. Yancopoulos, G.D., S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash. 2000. Vascular-specific growth factors and blood vessel formation. Nature. 407:242-248.
36. Yano, M., A. Iwama, H. Nishio, J. Suda, G. Takada, and T. Suda. 1997. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood. 89:4317-4326.